Ubs Asset Management Americas Inc Repligen Corp Transaction History

Ubs Asset Management Americas Inc

  • $379 Billion
  • Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Repligen Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 252,497 shares of RGEN stock, worth $32.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
252,497
Previous 235,343 7.29%
Holding current value
$32.2 Million
Previous $33.9 Million 5.16%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 19, 2025
BUY
$127.24 - $174.24 $2.18 Million - $2.99 Million
17,154 Added 7.29%
252,497 $32.1 Million
Q4 2024

Feb 14, 2025
BUY
$123.41 - $160.92 $3.3 Million - $4.3 Million
26,733 Added 12.81%
235,343 $33.9 Million
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $17.4 Million - $24.3 Million
-145,254 Reduced 41.05%
208,610 $31 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $10.8 Million - $16.4 Million
89,801 Added 34.01%
353,864 $44.6 Million
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $171,463 - $209,253
1,004 Added 0.38%
264,063 $48.6 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $1.78 Million - $2.89 Million
15,614 Added 6.31%
263,059 $47.3 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $7.67 Million - $9.75 Million
55,258 Added 28.75%
247,445 $39.3 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $526,026 - $675,521
3,410 Added 1.81%
192,187 $32.4 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $6.29 Million - $8.54 Million
38,736 Added 25.82%
188,777 $32 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $2.3 Million - $3.67 Million
-14,315 Reduced 8.71%
150,041 $28.1 Million
Q2 2022

Aug 12, 2022
BUY
$140.68 - $188.02 $316,952 - $423,609
2,253 Added 1.39%
164,356 $26.7 Million
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $202,454 - $323,997
-1,256 Reduced 0.77%
162,103 $30.5 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $77,248 - $94,994
312 Added 0.19%
163,359 $43.3 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $1.21 Million - $2.01 Million
-6,199 Reduced 3.66%
163,047 $47.1 Million
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $904,820 - $1.21 Million
-5,455 Reduced 3.12%
169,246 $33.8 Million
Q1 2021

May 14, 2021
SELL
$180.37 - $226.26 $385,631 - $483,743
-2,138 Reduced 1.21%
174,701 $34 Million
Q4 2020

Mar 01, 2021
SELL
$148.08 - $206.57 $781,714 - $1.09 Million
-5,279 Reduced 2.9%
176,839 $33.9 Million
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $2.89 Million - $3.73 Million
23,580 Added 14.87%
182,118 $26.9 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $1.23 Million - $1.83 Million
13,036 Added 8.96%
158,538 $19.6 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $7.88 Million - $10.1 Million
92,761 Added 175.88%
145,502 $14 Million
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $369,790 - $466,144
5,008 Added 10.49%
52,741 $4.88 Million
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $587,139 - $731,606
7,660 Added 19.12%
47,733 $3.66 Million
Q2 2019

Aug 15, 2019
BUY
$54.2 - $85.95 $411,052 - $651,844
7,584 Added 23.34%
40,073 $0
Q1 2019

May 14, 2019
BUY
$49.45 - $62.8 $187,069 - $237,572
3,783 Added 13.18%
32,489 $0
Q4 2018

Feb 13, 2019
BUY
$48.26 - $68.88 $89,329 - $127,496
1,851 Added 6.89%
28,706 $1.51 Million
Q3 2018

Nov 14, 2018
BUY
$46.8 - $58.97 $125,330 - $157,921
2,678 Added 11.08%
26,855 $0
Q2 2018

Aug 14, 2018
BUY
$35.26 - $47.04 $202,004 - $269,492
5,729 Added 31.05%
24,177 $0
Q4 2017

Feb 09, 2018
BUY
$32.53 - $38.92 $26,642 - $31,875
819 Added 4.65%
18,448 $0
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $651,920 - $811,991
17,629
17,629 $0

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.6M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.07B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email